METHODS FOR SELECTION OF AGE-APPROPRIATE TISSUES
Methods of producing tissue matrices are provided. The methods can comprise selection of collagen-based tissues from animals based on desired mechanical and/or biologic properties relating to the age of a source animal. Furthermore, tissue matrices produced from animals including pigs selected at various ages to control mechanical properties are provided.
1 . A method for producing a tissue product, comprising:
identifying an anatomical site for treatment;
identifying a species of animal having a collagen-based tissue for use in treating the anatomical site;
identifying a desired set of mechanical properties suitable for treating the anatomical site;
selecting an animal of the identified species of an age at which a processed collagen-based tissue from the animal will comprise the desire set of mechanical properties;
procuring a collagen-based tissue from the selected animal; and
processing the collagen-based tissue to produce an acellular tissue matrix from the collagen-based tissue.
2 . The method of claim 1 , wherein the collagen-based tissue comprises dermis.
3 . The method of claim 1 , wherein the collagen-based tissue is selected fascia, pericardial tissue, dura, umbilical cord tissue, placental tissue, cardiac valve tissue, ligament tissue, tendon tissue, arterial tissue, venous tissue, neural connective tissue, urinary bladder tissue, ureter tissue, and intestinal tissue.
4 . The method of claim 1 , wherein the animal comprises a pig.
5 . The method of claim 1 , wherein the animal is selected from non-human primates, dogs, horses, cows.
6 . The method of claim 1 , wherein the set of mechanical properties includes at least one of strength, pliability, suture strength, elasticity, tensile strength, density, stiffness, and compressibility.
7 . The method of claim 1 , wherein the animal is further selected at an age at which the selected tissue has a desired degree of resistance to enzymatic digestion.
8 . The method of claim 1 , further comprising treating the tissue to removal alpha-1,3-galactose epitopes.
9 . The method of claim 1 , wherein the acellular tissue matrix comprises a pliable sheet.
10 . The method of claim 1 , wherein the selected animal is a pig between about 7 and 12 months old and the collagen-based tissue comprises dermis.
11 . The method of claim 1 , wherein the selected animal is a pig between about 8 and 10 months old and the collagen-based tissue comprises dermis.
12 . A tissue matrix, comprising:
an acellular dermal matrix derived from dermis of a pig between about 7 and 12 months.
13 . The tissue matrix of claim 12 , wherein the dermal matrix is derived from a pig between about 8 and 10 months old.
14 . The tissue matrix of claim 12 , wherein the tissue matrix has a strength sufficient for use as an abdominal wall treatment device.
15 . The tissue matrix of claim 12 , wherein the tissue matrix lacks alpha-1,3-galactose epitopes.
16 . The tissue matrix of claim 15 , wherein the tissue matrix has been treated to remove alpha-1,3-galactose epitopes.
17 . The tissue matrix of claim 12 , wherein the tissue matrix comprises a pliable sheet.
18 . An acellular tissue matrix produced according to the methods of claim 1 .
19 . A method of treating an anatomic site, comprising:
selecting an anatomic site having a defect;
selecting an acellular dermal matrix derived from dermis of a pig between about 7 and 12 months; and
securing the acellular dermal matrix in or on the anatomic site to treat the defect.
20 . The method of claim 19 , wherein the dermal matrix is derived from a pig between about 8 and 10 months old.
21 . The method of claim 19 , wherein the anatomic site comprises a load-bearing tissue.
22 . The method of claim 21 , wherein the anatomic site comprises a portion of an abdominal wall.
23 . The method of claim 21 , wherein the anatomic site comprises a midline abdominal incision.
24 . The method of claim 21 , wherein the anatomic site comprises an abdominal hernia.
25 . The method of claim 19 , wherein the acellular dermal matrix lacks alpha-1,3-galactose epitopes.
26 . The method of claim 25 , wherein the acellular dermal matrix has been treated to remove alpha-1,3-galactose epitopes.
27 . The method of claim 19 , wherein the acellular dermal matrix comprises a pliable sheet.